AT355008B - Verfahren zur herstellung neuer 1-(2-phenyl-2- hydroxyaethylamino)-3-phenoxypropan-2-ole und ihrer saeureadditionssalze - Google Patents

Verfahren zur herstellung neuer 1-(2-phenyl-2- hydroxyaethylamino)-3-phenoxypropan-2-ole und ihrer saeureadditionssalze

Info

Publication number
AT355008B
AT355008B AT67677A AT67677A AT355008B AT 355008 B AT355008 B AT 355008B AT 67677 A AT67677 A AT 67677A AT 67677 A AT67677 A AT 67677A AT 355008 B AT355008 B AT 355008B
Authority
AT
Austria
Prior art keywords
hydroxyaethylamino
phenoxypropan
ole
phenyl
acid addition
Prior art date
Application number
AT67677A
Other languages
English (en)
Other versions
ATA67677A (de
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of ATA67677A publication Critical patent/ATA67677A/de
Application granted granted Critical
Publication of AT355008B publication Critical patent/AT355008B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT67677A 1976-02-17 1977-02-03 Verfahren zur herstellung neuer 1-(2-phenyl-2- hydroxyaethylamino)-3-phenoxypropan-2-ole und ihrer saeureadditionssalze AT355008B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762606140 DE2606140A1 (de) 1976-02-17 1976-02-17 Neue derivate des 2-phenyl-2-hydroxyaethylamins

Publications (2)

Publication Number Publication Date
ATA67677A ATA67677A (de) 1979-07-15
AT355008B true AT355008B (de) 1980-02-11

Family

ID=5970017

Family Applications (1)

Application Number Title Priority Date Filing Date
AT67677A AT355008B (de) 1976-02-17 1977-02-03 Verfahren zur herstellung neuer 1-(2-phenyl-2- hydroxyaethylamino)-3-phenoxypropan-2-ole und ihrer saeureadditionssalze

Country Status (16)

Country Link
JP (1) JPS52100433A (de)
AT (1) AT355008B (de)
AU (1) AU512322B2 (de)
BE (1) BE851503A (de)
CH (4) CH634820A5 (de)
DE (1) DE2606140A1 (de)
DK (1) DK66177A (de)
ES (7) ES455942A1 (de)
FI (1) FI770170A (de)
FR (1) FR2341557A1 (de)
GB (1) GB1544883A (de)
IE (1) IE45186B1 (de)
LU (1) LU76774A1 (de)
NL (1) NL7701613A (de)
NO (1) NO143345C (de)
SE (1) SE7701724L (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0025331B1 (de) * 1979-09-06 1983-03-02 Beecham Group Plc Zimtsäurederivate, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE3125870C2 (de) * 1980-07-09 1994-09-15 William John Louis 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
WO2008120655A1 (ja) 2007-03-30 2008-10-09 Institute Of Medicinal Molecular Design, Inc. I型11βヒドロキシステロイド脱水素酵素阻害活性を有するオキサゾリジノン誘導体

Also Published As

Publication number Publication date
ATA67677A (de) 1979-07-15
NO770509L (no) 1977-08-18
ES464833A1 (es) 1978-09-01
CH635569A5 (en) 1983-04-15
FR2341557A1 (fr) 1977-09-16
ES464837A1 (es) 1978-08-01
ES464832A1 (es) 1978-09-01
DE2606140A1 (de) 1977-08-25
LU76774A1 (de) 1978-04-13
FR2341557B1 (de) 1980-08-14
NO143345C (no) 1981-01-21
IE45186B1 (en) 1982-07-14
AU2233477A (en) 1978-08-24
BE851503A (fr) 1977-08-16
NO143345B (no) 1980-10-13
IE45186L (en) 1977-08-17
AU512322B2 (en) 1980-10-02
NL7701613A (nl) 1977-08-19
GB1544883A (en) 1979-04-25
CH634821A5 (en) 1983-02-28
CH634822A5 (en) 1983-02-28
SE7701724L (sv) 1977-08-18
ES464836A1 (es) 1978-08-01
ES464834A1 (es) 1978-09-01
ES455942A1 (es) 1978-11-01
JPS52100433A (en) 1977-08-23
DK66177A (da) 1977-08-18
CH634820A5 (en) 1983-02-28
ES464835A1 (es) 1979-09-16
FI770170A (de) 1977-08-18

Similar Documents

Publication Publication Date Title
AT360013B (de) Verfahren zur herstellung neuer piperidin- derivate und ihrer salze
AT370734B (de) Verfahren zur herstellung neuer imidazochinoxaline und ihrer salze
AT366682B (de) Verfahren zur herstellung neuer 3-fluor-6piperazinylmorphanthridine und ihrer saeureadditionssalze
AT363474B (de) Verfahren zur herstellung neuer carbostyrilderivate und ihrer pharmazeutisch geeigneten saeureadditionssalze
AT372944B (de) Verfahren zur herstellung neuer substituierter pyrrolidine und ihrer saeureadditionssalze
AT370415B (de) Verfahren zur herstellung neuer 2-pyridylaminobenzoes[uren und ihrer salze
AT360513B (de) Verfahren zur herstellung neuer dimerer indol- -dihydroindol-carboxamide und ihrer salze
AT362350B (de) Verfahren zur herstellung neuer in 4-stellung substituierter 3-sulfamoylbenzoesaeuren und ihrer salze
AT355580B (de) Verfahren zur herstellung neuer pyridobenzo- diazepinone und ihrer salze
AT358037B (de) Verfahren zur herstellung neuer 1-amino-2- hydroxy-3-heterocyclyloxy-propane und ihrer salze
ATA342176A (de) Verfahren zur herstellung neuer 2-imidazolyl- chinazoline und ihrer salze
AT355008B (de) Verfahren zur herstellung neuer 1-(2-phenyl-2- hydroxyaethylamino)-3-phenoxypropan-2-ole und ihrer saeureadditionssalze
AT351020B (de) Verfahren zur herstellung neuer 4-phenyl- imidazoline und ihrer saeureadditionssalze
AT377256B (de) Verfahren zur herstellung neuer 1-phenaethylimidazol-derivate und ihrer saeureadditionssalze
ATA393679A (de) Verfahren zur herstellung neuer 1-(2-phenyl-2-hydroxyaethylamino)-3-phenoxy-propan-2-olen und derensaeureadditionssalzen
ATA451579A (de) Verfahren zur herstellung neuer oxathiaverbindungen und ihrer salze
AT352713B (de) Verfahren zur herstellung neuer 1-azidoalkyl- imidazole und ihrer saeureadditionssalze
AT355582B (de) Verfahren zur herstellung neuer pyridobenzo- diazepinone und ihrer salze
AT362348B (de) Verfahren zur herstellung neuer naphthylamin- derivate und ihrer saeureadditionssalze
ATA338079A (de) Verfahren zur herstellung neuer 1-amino-2- -hydroxy-3-heterocyclyloxy-progane und ihrer salze
ATA966475A (de) Verfahren zur herstellung neuer diazepinoiso- chinoline und ihrer saeureadditionssalze
ATA8079A (de) Verfahren zur herstellung neuer allylaminderivate und ihrer saeureadditionssalze
AT371115B (de) Verfahren zur herstellung neuer 1,2,3,4-tetrahydro-2-piperazinyl-naphthaline und ihrer saeureadditionssalze
ATA307581A (de) Verfahren zur herstellung neuer 1,2,3,4-tetrahydro-2-piperazinyl-naphthaline und ihrer saeureadditionssalze
ATA777479A (de) Verfahren zur herstellung neuer in 4-stellung substituierter 3-sulfamoyl-5-pyrrolyl- bzw. -5-pyrrolylalkyl-benzoesaeuren und ihrer salze

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee